85% of Physicians Polled Believe Patient Care Improved Through Use of Sermo & Social Media
Press Releases
U.S. Doctors say quality of medicine will decline in 5 years
62% Are Pessimistic about the American Physician’s Ability to Practice Independently or in Small Groups in the Future.
64% Strongly Agree/Agree Their Clinical Decisions are Being Based More on What Payors are Willing to Cover Rather Than What They Think is Best for Their Patients.
Senator Coburn MD (R. OK) taps Sermo on healthcare bill
81% of Physicians Polled Do Not Believe the Proposed Health Care Bill Will Achieve Sustainable, Affordable Reform
Medicare patients to be turned away if reimbursement is cut
Physicians on Sermo Respond to 21% Medicare Cuts
Athenahealth and Sermo partner to improve patient care
athenahealth-Sermo Data Shows Physicians Remarkably Optimistic about Electronic Health Records, with 80% Holding Favorable Views of EHRs; Despite this 90% Agree EHRs Are Expensive to Purchase and 72% Agree EHRs Still Require Effort to Stay Current with Changing Payment Requirements and Incentives
Sermo Named One of World’s Most Innovative Companies
Largest Physician Community Recognized as ‘Political Force’ Behind Healthcare Reform Efforts
26% of solo practitioners on Sermo forced to close doors
Physicians Nationwide Discuss Causes of Struggling Practices and Possible Alternatives
Physicians stunned by FTC complaint of Medicare refusal
Physicians Shocked and Speechless After Complaint Against Roaring Fork Valley Physicians IPA
Tasigna front line data strong; but won’t displace gleevec
Oncologists on Sermo Positive About New Findings in CML but Looking for More Data points
Religion is a popular topic among US physicians on Sermo
Physicians Nationwide Debate Existence of Afterlife
Mayo Clinic of Arizona to drop Medicare for primary care
Physicians Nationwide React to Announcement that Mayo Clinic of Arizona Will Stop Accepting Medicare Patients
Neurologists eagerly await Cladribine and Fingolimod
Majority of Neurologists need more long-term safety data before prescribing oral MS agents as first line therapy